 Tristan Huie
Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 10 | 2020 | 505 | 1.800 |
Why?
| | Hemoptysis | 2 | 2023 | 34 | 1.090 |
Why?
| | Lung Diseases, Interstitial | 10 | 2017 | 507 | 0.940 |
Why?
| | Simulation Training | 1 | 2023 | 62 | 0.820 |
Why?
| | Education, Medical | 1 | 2023 | 216 | 0.730 |
Why?
| | Tomography, X-Ray Computed | 5 | 2019 | 2269 | 0.510 |
Why?
| | Physicians | 1 | 2023 | 772 | 0.500 |
Why?
| | Alveolitis, Extrinsic Allergic | 4 | 2019 | 86 | 0.490 |
Why?
| | Arthritis, Rheumatoid | 4 | 2017 | 1002 | 0.450 |
Why?
| | Pulmonary Fibrosis | 3 | 2012 | 322 | 0.430 |
Why?
| | Emphysema | 1 | 2013 | 107 | 0.410 |
Why?
| | Clinical Trials as Topic | 1 | 2015 | 934 | 0.360 |
Why?
| | Smoking | 2 | 2017 | 1384 | 0.290 |
Why?
| | Clinical Competence | 2 | 2023 | 896 | 0.280 |
Why?
| | Connective Tissue Diseases | 3 | 2013 | 71 | 0.230 |
Why?
| | Patient Acuity | 1 | 2024 | 42 | 0.220 |
Why?
| | Teaching Rounds | 1 | 2024 | 64 | 0.210 |
Why?
| | Workload | 1 | 2024 | 132 | 0.210 |
Why?
| | Lung | 6 | 2019 | 3546 | 0.200 |
Why?
| | Equipment Design | 1 | 2023 | 508 | 0.190 |
Why?
| | Humans | 27 | 2024 | 114714 | 0.180 |
Why?
| | Biomarkers | 1 | 2010 | 3414 | 0.170 |
Why?
| | Intensive Care Units | 1 | 2024 | 618 | 0.170 |
Why?
| | Lung Transplantation | 2 | 2020 | 246 | 0.170 |
Why?
| | Computer Simulation | 1 | 2023 | 878 | 0.170 |
Why?
| | Cause of Death | 2 | 2019 | 362 | 0.160 |
Why?
| | Sarcoidosis | 2 | 2011 | 135 | 0.160 |
Why?
| | Radiologists | 1 | 2019 | 35 | 0.160 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2019 | 63 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 250 | 0.150 |
Why?
| | Curriculum | 1 | 2023 | 824 | 0.150 |
Why?
| | Mortality | 1 | 2019 | 288 | 0.140 |
Why?
| | Vital Capacity | 5 | 2017 | 256 | 0.140 |
Why?
| | Cognition | 1 | 2024 | 983 | 0.140 |
Why?
| | Toll-Like Receptors | 1 | 2017 | 166 | 0.140 |
Why?
| | Common Variable Immunodeficiency | 1 | 2016 | 24 | 0.130 |
Why?
| | Granuloma | 1 | 2016 | 83 | 0.130 |
Why?
| | RNA Splicing | 1 | 2017 | 245 | 0.130 |
Why?
| | Alternative Splicing | 1 | 2017 | 188 | 0.130 |
Why?
| | Forced Expiratory Volume | 2 | 2015 | 476 | 0.130 |
Why?
| | Registries | 2 | 2020 | 1759 | 0.120 |
Why?
| | Male | 19 | 2024 | 55558 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1340 | 0.120 |
Why?
| | Radiographic Image Enhancement | 1 | 2015 | 52 | 0.120 |
Why?
| | Leukocytes, Mononuclear | 1 | 2017 | 493 | 0.120 |
Why?
| | Medical History Taking | 1 | 2015 | 114 | 0.120 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 4622 | 0.120 |
Why?
| | Female | 19 | 2024 | 59485 | 0.120 |
Why?
| | Survival Analysis | 3 | 2017 | 1218 | 0.120 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 148 | 0.110 |
Why?
| | Middle Aged | 14 | 2019 | 26746 | 0.110 |
Why?
| | Aged | 12 | 2020 | 19079 | 0.110 |
Why?
| | Bronchiolitis Obliterans | 1 | 2013 | 66 | 0.100 |
Why?
| | Mycophenolic Acid | 1 | 2013 | 77 | 0.100 |
Why?
| | Lymphatic Vessels | 1 | 2012 | 54 | 0.100 |
Why?
| | Bronchial Diseases | 1 | 2012 | 38 | 0.100 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 353 | 0.100 |
Why?
| | Pulmonary Diffusing Capacity | 3 | 2017 | 60 | 0.100 |
Why?
| | Respiratory Function Tests | 4 | 2014 | 524 | 0.100 |
Why?
| | Collagen | 1 | 2012 | 415 | 0.090 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 253 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2017 | 2557 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2538 | 0.090 |
Why?
| | Aged, 80 and over | 5 | 2012 | 6346 | 0.090 |
Why?
| | United States | 8 | 2020 | 12176 | 0.080 |
Why?
| | Gastroesophageal Reflux | 1 | 2012 | 234 | 0.080 |
Why?
| | Pulmonary Embolism | 1 | 2011 | 181 | 0.080 |
Why?
| | Immunosuppressive Agents | 1 | 2013 | 647 | 0.080 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2012 | 200 | 0.080 |
Why?
| | Kaplan-Meier Estimate | 3 | 2015 | 815 | 0.080 |
Why?
| | Fibroblasts | 1 | 2012 | 838 | 0.080 |
Why?
| | Multivariate Analysis | 3 | 2016 | 1435 | 0.070 |
Why?
| | Disease Progression | 3 | 2020 | 2384 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2010 | 298 | 0.070 |
Why?
| | Respiratory Insufficiency | 1 | 2010 | 291 | 0.070 |
Why?
| | Survival Rate | 3 | 2015 | 1642 | 0.070 |
Why?
| | Biopsy | 3 | 2014 | 1040 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2020 | 1080 | 0.060 |
Why?
| | Signal Transduction | 1 | 2017 | 4521 | 0.060 |
Why?
| | Autoantibodies | 1 | 2012 | 1350 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2016 | 3004 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2013 | 12512 | 0.050 |
Why?
| | Radiography | 2 | 2016 | 811 | 0.050 |
Why?
| | Sex Distribution | 2 | 2012 | 335 | 0.040 |
Why?
| | Risk Factors | 4 | 2016 | 8626 | 0.040 |
Why?
| | Occupations | 1 | 2019 | 36 | 0.040 |
Why?
| | Logistic Models | 2 | 2016 | 1843 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 90 | 0.040 |
Why?
| | Biological Specimen Banks | 1 | 2019 | 94 | 0.040 |
Why?
| | Prognosis | 2 | 2017 | 3334 | 0.040 |
Why?
| | Forecasting | 1 | 2019 | 331 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2382 | 0.040 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2017 | 46 | 0.030 |
Why?
| | Hypersplenism | 1 | 2016 | 7 | 0.030 |
Why?
| | Leukopenia | 1 | 2016 | 27 | 0.030 |
Why?
| | RNA Precursors | 1 | 2017 | 136 | 0.030 |
Why?
| | Rheumatoid Factor | 1 | 2017 | 157 | 0.030 |
Why?
| | Prospective Studies | 2 | 2020 | 6216 | 0.030 |
Why?
| | Arthritis | 1 | 2016 | 110 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1449 | 0.030 |
Why?
| | Alberta | 1 | 2013 | 10 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor D | 1 | 2012 | 12 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2012 | 16 | 0.030 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 24 | 0.030 |
Why?
| | Cohort Studies | 2 | 2015 | 4899 | 0.030 |
Why?
| | Patient Dropouts | 1 | 2013 | 66 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 117 | 0.020 |
Why?
| | Adult | 4 | 2016 | 30543 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1126 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 511 | 0.020 |
Why?
| | Age Distribution | 1 | 2011 | 339 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 494 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 498 | 0.020 |
Why?
| | Exercise | 1 | 2020 | 1643 | 0.020 |
Why?
| | Cytokines | 1 | 2017 | 1843 | 0.020 |
Why?
| | Risk | 1 | 2011 | 815 | 0.020 |
Why?
| | Sex Factors | 1 | 2013 | 1717 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 284 | 0.020 |
Why?
| | Chronic Disease | 1 | 2013 | 1590 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 2481 | 0.020 |
Why?
| | Young Adult | 2 | 2012 | 10462 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 912 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2013 | 4420 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 6124 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 17808 | 0.010 |
Why?
|
|
Huie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|